Literature DB >> 2385826

Brain resection for exposure of deep extracerebral and paraventricular lesions.

R C Heros1.   

Abstract

In exposing deep extracerebral or paraventricular lesions, it sometimes may be preferable to resect a small amount of noneloquent brain tissue rather than retract the brain. This may be the case in carefully selected instances when, in the surgeon's estimate, brain retraction may result in significant parenchymal damage, in aneurysmal rupture, or in damage to important bridging veins. Some surgical approaches involving brain resection have been well described. This technical note discusses the following approaches that, though undoubtedly used by many surgeons sporadically, have received less formal attention: (1) anterior-inferior temporal resection for basilar aneurysms, (2) posterior-inferior temporal resection to approach the posterior incisura and avoid damage to the vein of Labbé, (3) parahippocampal resection to expose the posterior cerebral artery in the ambient cistern, (4) paramedial posterior parietal incision to approach the trigone of the lateral ventricle, (5) parasagittal resection to expose the interhemispheric fissure and avoid damage to bridging veins, (6) cingulate resection for pericallosal aneurysms, and (7) tonsillar resection for aneurysms of the peripheral portion of the posterior-inferior cerebellar arteries.

Entities:  

Mesh:

Year:  1990        PMID: 2385826     DOI: 10.1016/0090-3019(90)90073-x

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  2 in total

1.  Dorsal internal carotid artery aneurysm: classification, pathogenesis, and surgical considerations.

Authors:  A Diraz; K Kyoshima; S Kobayashi
Journal:  Neurosurg Rev       Date:  1993       Impact factor: 3.042

Review 2.  Microsurgical resection of tumors of the lateral and third ventricles: operative corridors for difficult-to-reach lesions.

Authors:  Ulas Cikla; Kyle I Swanson; Abdulfettah Tumturk; Nese Keser; Kutluay Uluc; Aaron Cohen-Gadol; Mustafa K Baskaya
Journal:  J Neurooncol       Date:  2016-05-27       Impact factor: 4.130

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.